OmegaGenesis is a bio-technology company developing nano-materials for human
body management to effectively treat conditions where the growth or anti-growth
of blood cells determines the outcome.
Human body management applications where blood vessels greatly determine the
outcome range from cancer and malignancies treatments to common wound healing
and skin reactivation.
OmegaGenesis was founded to discover and produce suitable nano-materials to
manage human body functions at nano scale - the cell and sub-cell level
-- accelerating cellular-based biologic therapies. These nano-materials will
enable Doctors to treat disease at sub-cell level in a less intrusive manner
instead of treating the disease at the organ or tissue level.
Using Nanotechnology to Address Diabetic Foot Ulcers
In this interview, we speak with Stanford's Gu Group about their newly developed metal nanocluster-based material that's advancing nanoscale 3D printing.
Professor Andre Nel
In this interview, AZoNano speaks with Professor Andre Nel about his involvement in innovative research describing the development of a 'glass bubble' nanocarrier that could help drug formulations access pancreatic cancer cells.
Jingang Li, Ph.D.
In this interview, AZoNano speaks with Jingang Li from the University of California, Berkley, who offers an introduction to the Nobel Prize-winning technology, Optical Tweezers.
The MiniCapt® Pro is a remote microbial air sampler that is ideal for the pharmaceutical manufacturing industry.
This product profile outlines the NanoRacer High-Speed AFM from Bruker JPK.
NMR spectroscopy is a characterization technique that is extensively used by chemical researchers.